Treatment depends on the severity of the hyperglycemia and the estimated duration of the<unk>  treatment. Mild hyperglycemia in an immunocompetent patient may not require treatment if the<unk> s will be discontinued in a week or two. Moderate hyperglycemia carries an increased risk of infection, especially fungal, and especially in people with other risk factors such as immunocompromise or central intravenous lines. Insulin is the most common treatment.
Steroid diabetes
Ketosis-prone diabetes
Diet in diabetes
Diabetic hypoglycemia
Maturity onset diabetes of the young
Reactive hypoglycemia
Galmic
Cushing's syndrome